Maastricht-based Clementine raises €1.7 million to scale its AI-powered hearing care platform
Clementine, a Maastricht-based startup that has built an AI-powered platform to help hearing clinics convert leads into patients, has raised €1.7 million ($2 million) in Seed funding. The Seed round was led by Healthy.Capital, an Amsterdam-based early-stage HealthTech investor that has backed Pharmi, MS Sherpa, OpenUp, Datamonk, Clear.bio, among others. “Clementine combines deep domain expertise…
Maastricht-based startup Clementine has secured €1.7 million ($2 million) in Seed funding to expand its AI-powered hearing care platform. The round was led by Healthy.Capital, an Amsterdam-based HealthTech investor with experience backing startups such as Pharmi, MS Sherpa, and Clear.bio. Clementine's CEO, Vince van de Weijer, explained that the company's platform, known as ClementineAI, aims to transform the way people with hearing disabilities engage with hearing healthcare through an AI-powered solution.
The AI agent, Matthew, is available 24/7 to answer patients' questions without judgment or waiting, educate them, overcome emotional and practical barriers, and guide them toward appropriate care. This automation allows clinics to focus on converting leads into patients rather than handling administrative tasks. The funding will be used to enhance Clementine's AI capabilities and to forge new partnerships with hearing clinics, optical retailers, and other healthcare organizations.
Hearing loss affects an estimated 1.5 billion people globally, and only about 20% of those in need seek treatment, often waiting for more than eight years. Clementine hopes to provide a solution that encourages early engagement with hearing care through its judgement-free, always-available platform.
Written by urgent.news from EU-Startups's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
